Gaithersburg-Based Novavax Agrees To Supply COVID-19 Vaccine To EuropeGaithersburg-based company Novavax is working on a potential COVID-19 vaccine, and now, it's agreeing to supply the shot to Europe.
Maryland Officials Warn Of Lengthy Timeline On Coronavirus VaccineIt will likely be at least six to eight months longer before a coronavirus vaccine can be distributed in a best-case scenario, leading Maryland health officials and lawmakers said Wednesday as they make plans for the state.
Minority Groups Less Likely To Participate In COVID-19 Vaccine Studies; Researchers Say Trials Are SafeResearchers are urging Marylanders to take part in coronavirus vaccination studies as doctors seek to ensure possible participants they will not cut corners.
Novavax, Other Pharmaceutical Companies Pledge To Hold Off On Coronavirus Vaccine Until It's Proven To Be SafeNovavax is one of nine pharmaceutical companies pledging to make the safety of vaccinated people the top priority in the development of the first COVID-19 vaccines.
Coronavirus Vaccine Trial Results Expected By End Of Year, US Officials SayCompanies testing COVID-19 vaccines should know by the end of the year whether any can protect people from the virus, federal officials say.
Novavax Expected To File For COVID-19 Vaccine Approval In DecemberThe Gaithersburg-based company Novavax announced it expects to file for approval of its COVID-19 vaccine candidate in December.
One-Third Of Americans Wouldn't Get COVID-19 Vaccine If It Were Available Today, Poll FindsAs scientists race to produce a safe vaccine by next year, Americans remain skeptical about taking it.
Dozens Of Maryland Companies Get Billions To Help Find Coronavirus VaccineThe local race to find a coronavirus cure is getting some help.
Coronavirus Vaccine Trial By MD Biotech Company Novavax Underway In South AfricaA Maryland based biotechnology company announced the coronavirus vaccine it developed is moving into an efficacy trial phase.
Emergent BioSolutions Signs $174M Agreement To Expand Production Of Possible Coronavirus VaccineA Maryland-based company has signed a $174 million agreement to expand production of a coronavirus vaccine candidate.
Pfizer, BioNTech Phase One COVID-19 Vaccine Trials Showing Promise, UMD School Of Medicine SaysPreliminary data from the Pfizer, BioNTech Phase 1 mRNA COVID-19 vaccine trials are showing promise, according to the University of Maryland School of Medicine.
Coronavirus In Maryland: Biotech Lab Novavax Selected To Receive $1.6B In Federal Funding For COVID-19 Vaccine Clinical TrialA Maryland biotechnology company will receive $1.6 billion in federal funding to help them to continue to develop and hold a clinical trial for a coronavirus vaccine this year.
Novavax Expands Large-Scale Global Manufacturing To Create More Doses Of COVID-19 Vaccine CandidateGaithersburg-based Novavax is expanding to create more doses of its COVID-19 vaccine candidate.
Maryland-Based Novavax Announces Trials For Coronavirus Vaccine In AustraliaA U.S. biotechnology company announced the start of human trials in Australia of a vaccine for the coronavirus with hopes of releasing a proven vaccine this year.
University Of Maryland School Of Medicine Begins Coronavirus Vaccine TrialThe research will study the safety, efficacy, and dosing of an experimental mRNA -based vaccine.